Additive Neuroprotective Effects of Dietary Supplements in Parkinson's Disease
Author Information
Author(s): Shtilbans Alexander, Reintsch Wolfgang E., Piscopo Valerio E. C., Krahn Andrea I., Durcan Thomas M.
Primary Institution: Hospital for Special Surgery, Weill Cornell Medicine, and The Neuro’s Early Drug Discovery Unit (EDDU), McGill University
Hypothesis
Can combinations of tauroursodeoxycholic acid, co-enzyme Q10, and creatine provide additive neuroprotective effects in Parkinson's disease models?
Conclusion
The combination of tauroursodeoxycholic acid, co-enzyme Q10, and creatine shows significant neuroprotective effects in vitro for Parkinson's disease.
Supporting Evidence
- The combination of TUDCA, CoQ10, and creatine increased neurofilament heavy chain levels by 24% compared to untreated cells.
- The same combination also increased tubulin filament area by 16% compared to untreated cells.
- The triple combination significantly reduced proinflammatory cytokines IL-6 and TNF-α in microglial cells.
Takeaway
This study found that mixing three dietary supplements can help protect brain cells in people with Parkinson's disease.
Methodology
The study used induced pluripotent stem cell-derived dopaminergic neurons and microglial cells to test the effects of different combinations of the supplements.
Potential Biases
The study may not account for gender differences in Parkinson's disease, as it only used a female patient cell line.
Limitations
The study was conducted on a single cell line from one female patient, and further validation is needed across different patient demographics.
Participant Demographics
One female patient with sporadic idiopathic Parkinson's disease, aged 42, and one healthy female control, aged 41.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website